Sanofi plans to phase in its own rebate model for 25 drugs — including anti-inflammatory injectable Dupixent, one of the top ...
Insurers could save 20% in administrative costs and 10% in medical costs by harnessing the technology, experts said during a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback